Published 6 July 2023
This page was last reviewed and updated 15 September 2023
Mental health is a key area of the NHS Long Term Plan published in 2019.
This publication aims to describe the prescribing of medicines used to improve mental health in England that are subsequently dispensed in the community. They do not include data on medicines used in secondary care, prisons, or issued by a private prescriber.
The Medicines Used in Mental Health publication is an experimental Official Statistic release.
Of the 5 British National Formulary (BNF) sections covered in these statistics, 4 had increases in items and identified patients across 2022/23.
The only BNF section to decrease since 2021/22 was hypnotics and anxiolytics. Items fell by 2% to 14 million and identified patients fell by 2% to 1.9 million in 2022/23
There were 86 million antidepressant items prescribed in 2022/23, to an estimated 8.6 million identified patients.
Prescribing of Central Nervous System (CNS) stimulants and drugs for ADHD increased by 32% in adults over 18 and 12% in children 17 and under. 2022/23 was the first time that more adult patients have been prescribed drugs from this section than child patients, in the time period covered by these statistics.
Central Nervous System (CNS) stimulants and drugs for ADHD was the only BNF section with more male patients than female patients. In the other 4 this was the reverse, with more female patients than male patients.
We're collecting feedback about our publications. You can complete a short survey to help us make our statistical releases more useful and accessible.
The survey takes about 5 minutes to complete.
All responses will remain anonymous and you will not be identifiable in any report we produce.
If you have any questions, comments, or would like more information you can email email@example.com.
Responsible statistician: Grace Libby